Department of Organismal Biology, Uppsala University, Uppsala, Sweden.
Centre for Women's Mental Health during the Reproductive Lifespan (WOMHER), Uppsala University, Uppsala, Sweden.
BMJ Open. 2023 Apr 19;13(4):e066571. doi: 10.1136/bmjopen-2022-066571.
There has been a drastic increase in the reported number of people seeking help for gender dysphoria in many countries over the last two decades. Yet, our knowledge of gender dysphoria and related outcomes is restricted due to the lack of high-quality studies employing comprehensive approaches. This longitudinal study aims to enhance our knowledge of gender dysphoria; different aspects will be scrutinised, focusing primarily on the psychosocial and mental health outcomes, prognostic markers and, secondarily, on the underlying mechanisms for its origin.
The Swedish Gender Dysphoria Study is an ongoing multicentre longitudinal cohort study with 501 registered participants with gender dysphoria who are 15 years old or older. Participants at different phases of their clinical evaluation process can enter the study, and the expected follow-up duration is three years. The study also includes a comparison group of 458 age- and county-matched individuals without gender dysphoria. Data on the core outcomes of the study, which are gender incongruence and experienced gender dysphoria, body satisfaction and satisfaction with gender-affirming treatments, as well as other relevant outcomes, including mental health, social functioning and life satisfaction, are collected via web surveys. Two different research visits, before and after starting on gender-affirming hormonal treatment (if applicable), are planned to collect respective biological and cognitive measures. Data analysis will be performed using appropriate biostatistical methods. A power analysis showed that the current sample size is big enough to analyse continuous and categorical outcomes, and participant recruitment will continue until December 2022.
The ethical permission for this study was obtained from the Local Ethical Review Board in Uppsala, Sweden. Results of the study will be presented at national and international conferences and published in peer-reviewed journals. Dissemination will also be implemented through the Swedish Gender Dysphoria Study network in Sweden.
在过去的二十年中,许多国家报告寻求性别认同障碍治疗的人数急剧增加。然而,由于缺乏采用综合方法的高质量研究,我们对性别认同障碍和相关结果的了解受到限制。这项纵向研究旨在增进我们对性别认同障碍的认识;将主要关注社会心理和心理健康结果、预后标志物,其次是其起源的潜在机制,对不同方面进行仔细研究。
瑞典性别认同障碍研究是一项正在进行的多中心纵向队列研究,共有 501 名年龄在 15 岁及以上的有性别认同障碍的注册参与者。处于其临床评估过程不同阶段的参与者可以进入研究,预期的随访时间为三年。该研究还包括一个由 458 名年龄和县级匹配、无性别认同障碍的个体组成的对照组。通过网络调查收集研究的核心结果(即性别不一致和经历的性别认同障碍、身体满意度和对性别肯定治疗的满意度)以及其他相关结果的数据,包括心理健康、社会功能和生活满意度。计划进行两次不同的研究访问,一次在开始性别肯定激素治疗(如果适用)之前,一次在之后,以收集各自的生物和认知测量值。将使用适当的生物统计学方法进行数据分析。一项功效分析表明,目前的样本量足以分析连续和分类结果,参与者招募将持续到 2022 年 12 月。
该研究的伦理许可已获得瑞典乌普萨拉的地方伦理审查委员会的批准。研究结果将在国家和国际会议上展示,并发表在同行评议的期刊上。还将通过瑞典性别认同障碍研究网络在瑞典进行传播。